Aktie A0F6EE COSMO BIO COMPANY,LIMITED
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen Cosmo Bio Company,Limited

Aktien

A0F6EE

JP3298700000

3386

Markt geschlossen - Japan Exchange
Andere Börsenplätze
 08:00:00 27.05.2024 		% 5 Tage % 1. Jan.
993 JPY +0.61% Intraday Chart für Cosmo Bio Company,Limited +1.85% +1.02%
2023 Cosmo Bio Company,Limited meldet die Ergebnisse für das erste Quartal zum 31. März 2023 CI
2023 Cosmo Bio Company,Limited berichtet über die Ergebnisse für das Geschäftsjahr zum 31. Dezember 2022 CI

Andere Sprachen

Suchen
Ergebnisse ansehen
Schalten Sie alle Nachrichten frei: Seien Sie als Erster informiert und reagieren Sie vor den Märkten!
100% kostenlose Registrierung
Cosmo Bio Company,Limited Reports Earnings Results for the First Quarter Ended March 31, 2023
Cosmo Bio Company,Limited Reports Earnings Results for the Full Year Ended December 31, 2022
Tranche Update on Cosmo Bio Company,Limited's Equity Buyback Plan announced on February 12, 2021.
Cosmo Bio Company,Limited's Equity Buyback announced on February 12, 2021, has closed with 160,000 shares, representing 2.71% for ¥194.04 million.
Tranche Update on Cosmo Bio Company,Limited's Equity Buyback Plan announced on February 12, 2021.
Tranche Update on Cosmo Bio Company,Limited's Equity Buyback Plan announced on February 12, 2021.
Cosmo Bio Company,Limited announces an Equity Buyback for 160,000, representing 2.7% of its issued share capital shares, for ¥200 million.
Cosmo Bio Company,Limited authorizes a Buyback Plan.
MeSCue-Janusys Inc. announced that it has received ¥50 million in funding from Cosmo Bio Company,Limited
MeSCue-Janusys Inc. announced that it expects to receive ¥50 million in funding from Cosmo Bio Company,Limited and other investors
FIMECS, Inc. announced that it has received $2.3 million in funding from Takeda Pharmaceutical Company Limited, Cosmo Bio Company,Limited
Canopy Biosciences, LLC Announces Distribution Agreement with Cosmo Bio Co., Ltd. for Japan Life Science Market
C-LEcta Signs Sales and Distribution Agreement with Cosmo Bio Co., Ltd. for Japan
Organovo Holdings Signs Exclusive Distributor Agreement with Cosmo Bio Co., Ltd
SOLA Biosciences LLC Announces Distribution Agreement with Cosmo Bio Co., LTD
Avacta Group plc Names Cosmo Bio Co Ltd as Distributor in Japan for Affimers
Enzo Life Sciences, Inc. Expands Distribution Agreement with Cosmo Bio Co. Ltd
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A0F6EE Aktie
  4. Nachrichten Cosmo Bio Company,Limited
  5. Andere Sprachen